This is specifically exemplified in colorectal cancer, where 5-FU activation of the XRE1–ABCB1–XBP1 pathway enhances ABC protein expression, promoting resistance to fluorouracil [102]. The gene discussed is XBP1; the disease is colorectal cancer.